Amsterdam Cardiovascular Sciences

Researchers from the Intensive Care Medicine and Physiology departments were the first in the world to show that diaphragm muscle fibers possess the required receptors for the corona virus and that virus particles invaded the diaphragm muscle fibers.

Researchers of the Vascular Medicine department were one of the first to publish about the risk of venous thromboembolism (VTE) in COVID-19 patients.

International phase III trial targeting the complement system to treat severe COVID-19.

Translational COVID-19 research that has led to clinical application of imatinib with the potential of a global impact.

With the help of Marfan patients and their families, researchers at the Medical Biochemistry and Clinical Genetics departments are able to study novel ways to treat Marfan syndrome and its symptoms.

Two heart patients who are passionately committed to the involvement of patients in cardiovascular research at Amsterdam UMC and beyond.

The Amsterdam UMC Heart Center has developed a successful research collaboration with the Amsterdam University of Applied Science, Faculty of Health.

Studying the impact of mechanical forces on endothelial interactions with the extracellular surroundings and the contacts between endothelial cells by using advanced microscopy approaches.

Targeting the gut microbiome serves as a preventive measure for the development of type 2 diabetes or to lower the burden on those already affected.

Immunotherapy is integrated in oncology treatment, but the exploitation in cardiovascular disease is in its infancy. Lowering inflammation is an important strategy for combating cardiovascular disease.

Researchers of the Experimental Cardiology department work together to unravel the underlying mechanisms of hereditary forms of heart failure.